Spark Therapeutics (NYSE: ONCE) executes option deal with Clearside Biomedical for ocular micro-injector technology.
Spark Therapeutics, Inc. (NASDAQ: ONCE) and Clearside Biomedical, Inc. (Alpharetta, Georgia, USA) have announced the execution of an option agreement to facilitate a potential acquisition… Read More »Spark Therapeutics (NYSE: ONCE) executes option deal with Clearside Biomedical for ocular micro-injector technology.